Changchun Genescience Pharmaceutical Co., Ltd.

This early-stage study tests whether a single shot of GenSci161 is safe and how the body processes it. About 44 healthy adults aged 18 to 45 will take part. No treatment is given—this is purely to gather safety and drug-level information.